Filing Details
LB PHARMACEUTICALS INC (NASDAQ:LBRX) filed a Form 8-K with the Securities and Exchange Commission on July 29, 2026, disclosing a material event.
8k filedNASDAQ:LBRX
LB PHARMACEUTICALS INC (LBRX) Reports Material Event to SEC
Filing Details LB PHARMACEUTICALS INC (NASDAQ:LBRX) filed a Form 8-K with the Securities and Exchange Commission on July 29, 2026, disclosing a material event. Market Context LB…
Market Context
LB PHARMACEUTICALS INC's stock currently trades at $39.00 with a market capitalization of $508.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for LB PHARMACEUTICALS INC's stock.
All SEC filings for LB PHARMACEUTICALS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LBRX Stock Page
Frequently Asked Questions
Where can I read LBRX's SEC filings?
Browse all filings on our LBRX SEC filings page.
What types of SEC filings does LB PHARMACEUTICALS INC file?
Public companies like LB PHARMACEUTICALS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.